US.TECH · Bio-Techne

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 0.3782662795520531,
        "turnoverUsdM": 137.29745696999998,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1.2
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.TECH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 71.7828,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2.5,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 5,
      "stop_loss_percent": 0.8,
      "take_profit_price": 75.9465,
      "target_multiplier": 1.9,
      "technical_strength": 1.65,
      "take_profit_percent": 5
    },
    "positionPoints": 1.6,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.6666666666666667,
    "stopLossPercent": 3,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 65.8,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60.8,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 5
  },
  "market": {
    "ma20": 72.2025,
    "ma50": 69.6006,
    "close": 72.33,
    "prevClose": 72.39,
    "avgVolume20": 3235330,
    "volumeRatio": 0.59,
    "changePercent": -0.08
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 5,
    "details": {
      "ret_5d": 0.001523123788424341,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 5,
      "vcp_bonus": 0,
      "vol_ratio": 0.5377804408860785,
      "ret_points": 4,
      "vol_points": 0,
      "range_ratio": 0.38020784303170135,
      "volat_points": 0,
      "day_range_pct": 0.0013825521913451448,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 65.8,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 50,
        "contribution": 2.5
      },
      {
        "raw": 10.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 54,
        "contribution": 10.8
      },
      {
        "raw": 12,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 80,
        "contribution": 12
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 78,
        "contribution": 7.8
      },
      {
        "raw": 19.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 65.67,
        "contribution": 19.7
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60.8,
    "details": [
      "基本面分析總分: 2.5/5分",
      "資金流分析總分: 10.8/20分",
      "市場環境分析總分: 12/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.8/10分",
      "技術信號分析總分: 19.7/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.5,
      "資金流": 10.8,
      "市場環境": 12,
      "情緒分析": 6,
      "技術信號": 19.7,
      "風險管理": 7.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 137.29745696999998,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.4
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 1.6,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.TECH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "優秀",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.85
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 712.1600008500002,
                "ma50": 713.0132008399997,
                "name": "QQQ",
                "close": 710.71997,
                "points": 0.4
              },
              "spy": {
                "ma20": 764.7984983,
                "ma50": 752.747003,
                "name": "SPY",
                "close": 765.90997,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 0.3782662795520531,
          "atrPoints": 4,
          "cciPoints": 3.2,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141206752,
                "url": "https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.",
                "category": "company",
                "datetime": 1786626060,
                "headline": "TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"
              },
              {
                "id": 141204891,
                "url": "https://finnhub.io/api/news?id=145fc12944ce1e55b01af88717d7fcd693646a77f5e8c53179970f0cfe5a49d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786535402,
                "headline": "Techne (TECH) Q4 Earnings Meet Estimates"
              },
              {
                "id": 141202745,
                "url": "https://finnhub.io/api/news?id=ede2069c356f711c5c50a96d08642cfb212030b7caf9c085e6134f46c062f61d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786534647,
                "headline": "Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales"
              },
              {
                "id": 141152622,
                "url": "https://finnhub.io/api/news?id=c9492fa4f38feb18d91c4edd3721f8c07927bf8b67c49c465d4f40ed0903f96b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne stock has delivered a strong 44.2% return over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a premium rather than as an obvious bargain. Over the last 12 months, Bio-Techne has returned 44.2%, which puts a clear spotlight on whether recent gains already reflect much of the good news in the price. Expectations around Bio-Techne's ability to grow revenue and sustain healthy cash flows...",
                "category": "company",
                "datetime": 1786133659,
                "headline": "Is Bio-Techne (TECH) Above Fair Value After A 44% Return?"
              },
              {
                "id": 141137529,
                "url": "https://finnhub.io/api/news?id=0ce6cf03d346d488db74cb61ae6e7de19e4e6d91d1481037fc87188e3eb09a78",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "JAZZ vs. TECH: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1786030803,
                "headline": "JAZZ vs. TECH: Which Stock Is the Better Value Option?"
              },
              {
                "id": 141134327,
                "url": "https://finnhub.io/api/news?id=d0fc9c909156b4e3d92e78dbcb1f92dcdd1813f9e834605c2a80d44142e2b05c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI […]",
                "category": "company",
                "datetime": 1786024651,
                "headline": "Investors’ Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases"
              }
            ],
            "raw_source": [
              {
                "id": 141279422,
                "url": "https://finnhub.io/api/news?id=6923c1cc8f112e10dd5ad9d09823f56d409c83dd9e29bc30f7d851606e748f6b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "BIO's digital PCR gains and recurring diagnostics base support growth, but a 40.2X forward P/E and muted 2026 outlook keep valuation risk in focus.",
                "category": "company",
                "datetime": 1787326260,
                "headline": "Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?"
              },
              {
                "id": 141285994,
                "url": "https://finnhub.io/api/news?id=daf4a629089d8f9e095f46c70670711c9ee0c32ab5dca24482a04c58e554bb62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne has outperformed the broader market over the past year, but analysts are cautious about the stock’s prospects.",
                "category": "company",
                "datetime": 1787050238,
                "headline": "Is Wall Street Bullish or Bearish on Bio-Techne Stock?"
              },
              {
                "id": 141285995,
                "url": "https://finnhub.io/api/news?id=9d830f74e586b86a2df937c7d17ccf401031341507955ec275356e50261935d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "“You get what you pay for” often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.",
                "category": "company",
                "datetime": 1787007020,
                "headline": "3 High-Flying Stocks We Approach with Caution"
              },
              {
                "id": 141219177,
                "url": "https://finnhub.io/api/news?id=9dc21aea1bd671a42c17cf25683ce0b07533c7514480b856f307022b024fa85f",
                "image": "",
                "source": "Benzinga",
                "related": "TECH",
                "summary": "Wells Fargo  analyst Brandon Couillard   downgrades Bio-Techne (NASDAQ:TECH) from Overweight to Equal-Weight and raises the price target from $62 to $73.",
                "category": "company",
                "datetime": 1786642576,
                "headline": "Wells Fargo Downgrades Bio-Techne to Equal-Weight, Raises Price Target to $73"
              },
              {
                "id": 141206752,
                "url": "https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.",
                "category": "company",
                "datetime": 1786626060,
                "headline": "TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"
              },
              {
                "id": 141204890,
                "url": "https://finnhub.io/api/news?id=9406225dd488595e8f2ad879c7709d8811f292e4cdbc3e751afe48f8f25b325b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne Corporation (NASDAQ: TECH) is issuing a correction to its dividend announcement released yesterday. The initial version incorrectly stated the shareholder of record date as August 17, 2026. The correct shareholder of record date is August 24, 2026. All other information contained in the dividend announcement remains unchanged.",
                "category": "company",
                "datetime": 1786617000,
                "headline": "Bio-Techne Corrects Dividend Announcement"
              },
              {
                "id": 141204891,
                "url": "https://finnhub.io/api/news?id=145fc12944ce1e55b01af88717d7fcd693646a77f5e8c53179970f0cfe5a49d6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Techne (TECH) delivered earnings and revenue surprises of 0.00% and +1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1786535402,
                "headline": "Techne (TECH) Q4 Earnings Meet Estimates"
              },
              {
                "id": 141202745,
                "url": "https://finnhub.io/api/news?id=ede2069c356f711c5c50a96d08642cfb212030b7caf9c085e6134f46c062f61d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Life sciences company Bio-Techne (NASDAQ:TECH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.3% year on year to $321.2 million. Its non-GAAP profit of $0.52 per share was in line with analysts’ consensus estimates.",
                "category": "company",
                "datetime": 1786534647,
                "headline": "Bio-Techne (NASDAQ:TECH) Surprises With Q2 CY2026 Sales"
              },
              {
                "id": 141202747,
                "url": "https://finnhub.io/api/news?id=a7e01a424982cbf1b9eefe452d652dad9b4a7c63f36785bac63834e8044fbfcd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended June 30, 2026. The quarterly dividend will be payable August 28, 2026, to all common shareholders of record on August 17, 2026. Future cash dividends will be considered by the Board of Directors on a quarterly basis.",
                "category": "company",
                "datetime": 1786530600,
                "headline": "Bio-Techne Declares Dividend"
              },
              {
                "id": 141202746,
                "url": "https://finnhub.io/api/news?id=c0f2ff78f72475d1797326fe1bba1f4f571bb5e8d8efbe477118d9131dfd087d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ending June 30, 2026.",
                "category": "company",
                "datetime": 1786530600,
                "headline": "Bio-Techne Releases Fourth Quarter Fiscal 2026 Results"
              },
              {
                "id": 141197930,
                "url": "https://finnhub.io/api/news?id=bc376ed2ba05725913becda94402bfb8027c2f2b313a98323c8553dc2a67c224",
                "image": "",
                "source": "Benzinga",
                "related": "TECH",
                "summary": "Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. This is a 1.89 percent decrease over earnings of $0.53 per share from the same period last year.  The",
                "category": "company",
                "datetime": 1786516866,
                "headline": "Bio-Techne Q4 Adj. EPS $0.52, Inline, Sales $321.191M Beat $314.679M Estimate"
              },
              {
                "id": 141152622,
                "url": "https://finnhub.io/api/news?id=c9492fa4f38feb18d91c4edd3721f8c07927bf8b67c49c465d4f40ed0903f96b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Bio-Techne stock has delivered a strong 44.2% return over the past year, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a premium rather than as an obvious bargain. Over the last 12 months, Bio-Techne has returned 44.2%, which puts a clear spotlight on whether recent gains already reflect much of the good news in the price. Expectations around Bio-Techne's ability to grow revenue and sustain healthy cash flows...",
                "category": "company",
                "datetime": 1786133659,
                "headline": "Is Bio-Techne (TECH) Above Fair Value After A 44% Return?"
              },
              {
                "id": 141137529,
                "url": "https://finnhub.io/api/news?id=0ce6cf03d346d488db74cb61ae6e7de19e4e6d91d1481037fc87188e3eb09a78",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "JAZZ vs. TECH: Which Stock Is the Better Value Option?",
                "category": "company",
                "datetime": 1786030803,
                "headline": "JAZZ vs. TECH: Which Stock Is the Better Value Option?"
              },
              {
                "id": 141134327,
                "url": "https://finnhub.io/api/news?id=d0fc9c909156b4e3d92e78dbcb1f92dcdd1813f9e834605c2a80d44142e2b05c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 and the Russell 2000 Growth Index up 25.7% in Q2, fueled by AI […]",
                "category": "company",
                "datetime": 1786024651,
                "headline": "Investors’ Confidence in Bio-Techne Corp. (TECH) Strengthens as Headwind Eases"
              },
              {
                "id": 141107198,
                "url": "https://finnhub.io/api/news?id=fb194183bfbf846f8edcdec5db45b99523c0f43806d3cb730bdb451ab0175a53",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
                "category": "company",
                "datetime": 1785836962,
                "headline": "2 S&P 500 Stocks to Keep an Eye On and 1 We Turn Down"
              },
              {
                "id": 141106192,
                "url": "https://finnhub.io/api/news?id=178e3d40886180e9f4da05c2578c624aba30285737e81c36d4cead923786b482",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 16.6% over the past six months while the S&P 500 was up 7.1%.",
                "category": "company",
                "datetime": 1785819682,
                "headline": "1 Healthcare Stock Worth Your Attention and 2 We Question"
              },
              {
                "id": 141077875,
                "url": "https://finnhub.io/api/news?id=996ca7a27b89564d8e6e716121ef72b099f03110093bdfa3431028dca299ca3c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2205618145/image_2205618145.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TECH",
                "summary": "The top five contributors for the quarter were MKS, Amphenol, Arista Networks, Bio-Techne, and Waters.",
                "category": "company",
                "datetime": 1785491340,
                "headline": "Madison Mid Cap Fund Q2 2026 Portfolio Activity"
              },
              {
                "id": 141077645,
                "url": "https://finnhub.io/api/news?id=5714fc9c6779de656a4e2a6b8b9d2ce3f672f1d8914a60d2ed397cf1fb5e57a1",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2205618145/image_2205618145.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TECH",
                "summary": "We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.",
                "category": "company",
                "datetime": 1785487080,
                "headline": "Conestoga SMid Cap Composite Q2 2026 Portfolio Review"
              },
              {
                "id": 141054556,
                "url": "https://finnhub.io/api/news?id=1d05afedea319df981c1c6f83addc02b5f0376cb79960f0906d78929147599c3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TECH",
                "summary": "TECH heads into fiscal fourth-quarter earnings with revenues expected to remain flat, EPS projected to decline, and its $11.3 billion acquisition deal in focus.",
                "category": "company",
                "datetime": 1785330300,
                "headline": "Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 19,
            "discarded_article_count": 13
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 19.7,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(2%→0.9%)；跌縮量(近10日3日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 5,
              "vol_ref": 3371526.6666666665,
              "down_days": 4,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 2711570,
              "avg_vol_20": 3529710,
              "avg_vol_30": 3371526.6666666665,
              "range_pct_10": 0.008571823586340448,
              "range_pct_20": 0.011889948845568913,
              "range_pct_30": 0.02046177243190936,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.8042558366239627,
              "dist_to_20d_high": 0.00399339025061975,
              "down_shrink_days": 3,
              "breakout_level_20d": 72.62,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4189189189189209
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 0.3782662795520531,
              "turnoverUsdM": 137.29745696999998,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1.2
            }
          },
          "rrPoints": 1.8,
          "stopLevels": {
            "symbol": "US.TECH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 71.7828,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2.5,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 5,
            "stop_loss_percent": 0.8,
            "take_profit_price": 75.9465,
            "target_multiplier": 1.9,
            "technical_strength": 1.65,
            "take_profit_percent": 5
          },
          "positionPoints": 1.6,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.6666666666666667,
          "stopLossPercent": 3,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 0.2736,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 8,
      "atr_pct": 0.38
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "適中偏強",
      "score": 8,
      "value": 66.98
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.1393
    },
    "kdj": {
      "d": 58.36,
      "j": 47.06,
      "k": 54.59,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 51.54
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 77971591,
      "recentSlope": -241580.9,
      "previousSlope": 804780
    },
    "rsi": 58.82,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 72.3149,
      "position": "SAR喺價下",
      "distancePct": 0.02,
      "previousTrend": "上升"
    },
    "ma50": 69.6006,
    "macd": {
      "macd": 0.8169456856432618,
      "trend": "中性偏多",
      "signal": 1.1034200725884897,
      "histogram": -0.286474386945228
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 72.1998,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 41
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.59,
      "score": 2,
      "avgVolume": 3235330,
      "currentVolume": 1898209
    },
    "derived": {
      "ma20": 72.2025,
      "ma50": 69.6006,
      "prevClose": 72.39,
      "avgVolume10": 2574981,
      "avgVolume20": 3235330,
      "changePercent": -0.08,
      "avgVolumeForScore": 3235330
    },
    "ma_cross": {
      "ma20": 72.2025,
      "ma50": 69.6006,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 72.1895,
      "prevMa50": 69.234,
      "spreadPct": 3.74,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 71.8982,
      "upper": 72.5068,
      "position": "上半部"
    },
    "rsi_short": 46.25,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.59
    }
  }
}

{
  "close": 72.33,
  "volume": 1898209,
  "changePercent": -0.08
}